Nexalin Technology, Inc. Accrued Marketing Costs, Current
Nexalin Technology, Inc. (NXL) had Accrued Marketing Costs, Current of $181.56 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedMarketingCostsCurrent · last filed 2026-08-12
- 2026-06-30: Accrued Marketing Costs, Current $181.56K.
| Period end | Accrued Marketing Costs, Current |
|---|---|
| 2026-06-30 | $181.56K 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |